{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-012366","form_type":"8-K","ticker":"IRD","cik":"0001228627","company_name":"Opus Genetics, Inc.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.749828+00:00","generated_at":"2026-05-23T20:43:29.840183+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Opus Genetics terminates $50M equity purchase agreement with Lincoln Park Capital","bullets":["Terminated Purchase Agreement with Lincoln Park Capital effective April 3, 2025.","Agreement allowed up to $50M in stock sales; company cites limited value given current market price.","Prior to termination, issued 1.7M shares for net proceeds of ~$5.2M; remaining $44.8M facility cancelled.","Registration obligations under the agreement survive termination for 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-012366","json":"https://secwatch.observer/filing/0001140361-25-012366.json","markdown":"https://secwatch.observer/filing/0001140361-25-012366.md","text":"https://secwatch.observer/filing/0001140361-25-012366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125012366/0001140361-25-012366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125012366/ef20046946_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T20:43:29.840183+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}